Smoking, nicotine and pregnancy 2 (SNAP2) trial: protocol for a randomised controlled trial of an intervention to improve adherence to nicotine replacement therapy in pregnancy

Clark, Miranda; Cooper, Sue; Naughton, Felix; Ussher, Michael; Emery, Joanne; Mcdaid, Lisa; Thomson, Ross; Phillips, Lucy; Bauld, Linda; Aveyard, Paul; Torgerson, David; Berlin, Ivan; Lewis, Sarah; Parrott, Steve; Hewitt, Catherine; Welch, Charlie; Parkinson, Gill; Dickinson, Anne; Sutton, Stephen; Brimicombe, James; Bowker, Kate; Mcewen, Andy; Vedhara, Kavita; Coleman, Tim

Abstract

Introduction: Smoking in pregnancy is harmful for unborn babies, infants, and women. Nicotine replacement therapy (NRT) is offered as usual stop smoking support in the UK. However, this is often used in insufficient doses, intermittently, or for too short a time to be effective. This randomised controlled trial (RCT) explores whether a bespoke intervention, delivered in pregnancy, improves adherence to NRT and is effective and cost effective for promoting smoking cessation.
Methods and analysis: A two-arm parallel-group RCT for pregnant women aged ≥ 16 years and who smoke ≥1 daily cigarette (pre-pregnancy smoked ≥5), and who agree to use NRT in a quit attempt. Recruitment is from antenatal care settings and via social media adverts. Participants are randomised using blocked randomisation with varying block sizes, stratified by gestational age (<14 weeks or ≥14 weeks) to receive: i) usual care stop smoking support (UC) or ii) UC plus an intervention to increase adherence to NRT, called “Baby, Me and NRT”, comprising adherence counselling, automated tailored text messages, a leaflet and website.
The primary outcome is biochemically validated smoking abstinence at or around childbirth, measured from 36 weeks gestation. Secondary outcomes include NRT adherence; other smoking measures; and birth outcomes. Questionnaires collect follow up data which are augmented by medical records information. We anticipate quit rates of 10% and 16% in control and intervention groups respectively (RR = 1.6). By recruiting 1320 participants the trial should have 90% power (alpha = 5%) to detect this intervention effect. An economic analysis will use the Economics of Smoking in Pregnancy (ESIP) model to determine cost-effectiveness.
Ethics and dissemination: Ethics approval was granted by Bloomsbury NHS Research Ethics Committee (21/LO/0123). Written informed consent will be obtained from all participants. Findings will be disseminated to the public, funders, relevant practice / policy representatives, researchers, and participants.
Trial registration: ISRCTN16830506

Citation

Clark, M., Cooper, S., Naughton, F., Ussher, M., Emery, J., Mcdaid, L., …Coleman, T. (2024). Smoking, nicotine and pregnancy 2 (SNAP2) trial: protocol for a randomised controlled trial of an intervention to improve adherence to nicotine replacement therapy in pregnancy. BMJ Open, 14(5), Article e087175. https://doi.org/10.1136/bmjopen-2024-087175

• Journal Article Type: Article
• Acceptance Date: Apr 24, 2024
• Online Publication Date: May 28, 2024
• Publication Date: 2024-05
• Deposit Date: Apr 25, 2024
• Publicly Available Date: Jun 6, 2024
• Journal: BMJ Open
• Publisher: BMJ Publishing Group
• Peer Reviewed: Peer Reviewed
• Volume: 14
• Issue: 5
• Article Number: e087175
• DOI: https://doi.org/10.1136/bmjopen-2024-087175
• Public URL: https://nottingham-repository.worktribe.com/output/34105480
• Publisher URL: https://bmjopen.bmj.com/content/14/5/e087175